We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 562

Biosimilar Approvals in the US and Canada - Sidestepping the 'Patent Dance'
  • Bereskin & Parr LLP
  • Canada, USA
  • January 12 2016

A passing moment of social awkwardness between a couple on a dance floor is nothing compared to the situation when the sidestepping is between two


Biosimilar Approvals in the US and Canada - the ‘Patent Dance’
  • Bereskin & Parr LLP
  • Canada, USA
  • December 30 2015

The US and Canada each provide an abbreviated pathway (or shortcut) for a biosimilar manufacturer to get a product approved. The shortcut allows for a


Latest Options for Fast-Tracking Clean Technology Patent Applications
  • Sterne Kessler Goldstein & Fox
  • Australia, Brazil, Canada, Israel, Japan, Taiwan, United Kingdom, USA
  • December 17 2015

The grant of a patent can be delayed by years due to backlogs at patent offices around the world. However, recognizing the urgent need to address


Public PAIR on steroids: global dossier goes live at USPTO
  • Bereskin & Parr LLP
  • Canada, USA
  • November 23 2015

As part of the ongoing world-wide effort to improve patent quality, the five major patent offices of the IP51 have a shared vision of improved global


An ounce of patents is worth a pound of cure
  • Bereskin & Parr LLP
  • Canada, USA
  • August 28 2015

The rug has been pulled out from under key patent rights of diagnostic companies and research institutions. A series of US court decisions have


FCA imposes could and would test to assess non-infringing alternative
  • Gowling Lafleur Henderson LLP
  • Canada, USA
  • July 30 2015

The Federal Court of Appeal has released its reasons in the appeal of Justice Snider’s lovastatin damages decision. Justice Snider awarded Merck $119


Law on post-patent royalties differs between Canada and the U.S.
  • Blake Cassels & Graydon LLP
  • Canada, USA
  • July 7 2015

The recent decision of the United States Supreme Court (USSC) in Kimble v. Marvel Entertainment LLC (Kimble) highlights how a lack of knowledge of


US and Ontario court jointly distribute $7.3 billion in liquidated assets of insolvent technology business: Nortel Networks Corporation (Re), 2015 ONSC 2987 (ONSC commercial list)
  • SIM. IP Practice
  • Canada, USA
  • June 4 2015

Nortel Networks Corporation was a telecommunications firm that filed for protection under the Companies' Creditors Arrangement Act ("CCAA") in 2009


Canadian defendant in U.S. patent infringement case wins big
  • Jeffer Mangels Butler & Mitchell LLP
  • Canada, USA
  • June 1 2015

Jeffer Mangels Butler & Mitchell LLP (JMBM) is pleased to announce that the Federal Circuit Court of Appeals affirmed the ruling of the U.S. District


Patent licensee’s standing to sue for infringement
  • Field Law
  • Canada, USA
  • May 12 2015

Although you might not think so, given the proliferation of litigation, courts are actually very particular about who can bring a lawsuit. In order